Diagnostic Test Kit

CoMira™ Logix Smart® ABC (influenza A/B, SARS-CoV-2) test kit

Boost speed and accuracy with real-time PCR testing

Key Features

Fast turnaround time for critical diagnostic decisions, enabling timely treatment and infection control measures.

Simultaneous detection of multiple respiratory pathogens including Influenza A, Influenza B, and SARS-CoV-2 in a single test.

Utilizes patented Co-Primers technology for enhanced specificity and sensitivity in pathogen detection.

Includes RNaseP internal positive control and reference standards to ensure reliable and accurate test results.

Rapid identification of respiratory infections in clinical settings for appropriate treatment decisions.

Enable effective infection control measures and patient management in healthcare facilities.

High-throughput testing capabilities for diagnostic laboratories and research facilities.

Distinguish between multiple respiratory pathogens with high accuracy

Multiplex testing reduces costs compared to individual tests

Faster diagnosis enables earlier treatment and better outcomes

Application	Qualitative Multiplex PCR test for detection and differentiation of influenza A, influenza B, and SARS-CoV-2
Sample type	Lower respiratory samples (bronchoalveolar lavage, sputum, tracheal aspirate); upper respiratory samples (nasopharyngeal and oropharyngeal swabs); saliva
Time to detection	Approximately 90 minutes, depending on instrument
Sensitivity	Influenza A 93% (68-100%); Influenza B 100% (78-100%); SARS-CoV-2 100% (88-100%)
Specificity	100% (88-100%) for all three targets
Limit of Detection	Influenza A 570 CEID₅₀/mL; Influenza B 60.0 CEID₅₀/mL; SARS-CoV-2 1000 copies/mL
Thermal cycler compatibility	CoMira Box™, MIC cycler, ECO48, CFX96, and most qPCR systems with FAM, CF560 (VIC), CF610 (ROX), QUASAR 670 (Cy5) channels
Extraction kit compatibility	QIAamp® Viral RNA Mini Kit (Qiagen, CAT